Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TLGT Teligent to RS 1-10 on May 28
*Teligent: Intends to Effectuate a Reverse Stk Split in the Ratio of 10:1 in Order to Remove the Uncertainty That a Potential De-Listing Presents to Current and Future Investors >TLGT
*Teligent: Anticipate the Reverse Split Will Be Effectuated on May 28 >TLGT
J.C. Penney files for bankruptcy, stock falls 29%
Today 6:53 PM ET (MarketWatch) 0.165 -0.0713 DIP $900M
J.C. Penney Co. Inc. (JCP) said late Friday that it had filed a Chapter 11 petition for the reorganization of the company and entered into a restructuring agreement with lenders holding roughly 70% of a portion of the company's debt. Shares of J.C. Penney fell 29% in the extended session. "The coronavirus (COVID-19) pandemic has created unprecedented challenges for our families, our loved ones, our communities, and our country," J.C. Penney Chief Executive Jill Soltau said in a statement. "As a result, the American retail industry has experienced a profoundly different new reality, requiring JCPenney to make difficult decisions in running our business to protect the safety of our associates and customers and the future of our company." The company said it would continue operations and that it had $500 million in cash as of the Chapter 11 filing date. It also said that it had received commitments for $900 million of debtor-in-possession financing from its existing debt holders. The company expects the money will be sufficient to meet its operational and restructuring needs. As part of its reorganization, J.C. Penney said it planned to close stores in phases, the first of which it will announce in the "coming weeks."
-Max A. Cherney; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
May 15, 2020 18:53 ET (22:53 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
JCP seeks @ $1B DIP in Bankrupt likely next wk
best Bk plays are those that have DIP coverage if can get for pennies like $0.15 and flip like done in Sears Bk initially
J.C. Penney seeking around $1 billion in bankruptcy funding: report
Today 9:08 PM ET (MarketWatch)
J.C. Penney Co. Inc. (JCP) is in advanced talks for bankruptcy funding, and is seeking a loan package of $800 million to $1 billion, the Wall Street Journal reported (https://www.wsj.com/articles/j-c-penney-in-advanced-talks-for-bankruptcy-financing-11587688846?mod=hp_lead_pos4) Thursday night. The Journal reported that the troubled retailer is in talks with existing lenders including Wells Fargo & Co., Bank of America Corp. and JPMorgan Chase & Co. for a debtor-in-possession loan that would keep the company's operations running during the bankruptcy process. A bankruptcy filing could come in the following weeks, the report said. Retailers, especially department stores, have been hard-hit by the coronavirus-related shutdown. Last week, Cowen analysts estimated that J.C. Penney had about seven months of operating cash left (http://www.marketwatch.com/story/nordstrom-can-withstand-12-months-of-store-closures-but-other-department-stores-have-much-less-time-analysts-say-2020-04-13). Penney's stock has tumbled 75% year to date, compared to the S&P 500's 13% decline.
-Mike Murphy; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
April 23, 2020 21:08 ET (01:08 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
QHC on hairy edge
Quorum Health Fell 56% on Shift in KKR Credit Advisors Talks
6:23 pm ET March 11, 2020 (Dow Jones)
By Josh Beckerman
Quorum Health Corp. shares fell 56% to 48 cents Wednesday after KKR Credit Advisors LLC said late Tuesday that transaction discussions shifted from a buyout plan to a reorganization with "no assurances" that stockholders would receive any consideration.
The proposal for the hospital operator, disclosed in December, called for a buyout of public shares held by minority holders for $1 each.
Quorum said late Wednesday that it "continues to engage in constructive discussions with KKR and other debt holders regarding a potential recapitalization or financial reorganization transaction." Shares rose 2 cents to 50 cents after hours.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
March 11, 2020 18:23 ET (22:23 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Delcath Sys DCTH says 1-700 for Dec. 24. Keeps A/S
Would be 3rd after 2 at 1-16 ratios. To be DCTHd 20 trade days.
Note A/S isn't being reduced leaving ample room for more you know what.
https://finance.yahoo.com/news/delcath-systems-announces-1-700-133010993.html?.tsrc=rss
NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company’s Board of Directors has authorized a 1-for-700 reverse stock split of the Company’s common stock. Stockholders authorized the Company’s Board of Directors to effect the reverse stock split at the annual meeting of stockholders on September 17, 2019. The reverse stock split will be effected prior to the initiation of trading on December 24, 2019. The reverse stock split supersedes the 1-for-100 reverse stock split previously announced on October 18, 2019 which was not effected.
Beginning with trading on December 24, 2019, shares of Delcath common stock will be designated by the symbol DCTHD for 20 trading days, and thereafter will revert to the symbol DCTH. The new CUSIP number for the common stock following the reverse stock split will be 24661P 807.
The reverse stock split will reduce the number of shares of common stock issued and outstanding or required to be reserved for issuance from approximately 1.4 billion to approximately 2.1 million but will not affect the authorized number of shares of common stock the Company is authorized to issue which will remain at 1 billion shares. Fractional shares resulting from the reverse stock split will be rounded up to whole shares.
American Stock Transfer & Trust Company, LLC is acting as the exchange agent and transfer agent for the reverse stock split. Stockholders holding their shares in book-entry form or in brokerage accounts need not take any action in connection with the reverse stock split. Beneficial holders are encouraged to contact their bank, broker or custodian with any procedural questions.
About Delcath System, Inc.
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product – Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) – is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. We have been enrolling a global Registration clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM) called The FOCUS Trial and have initiated a global Phase 3 clinical trial for intrahepatic cholangiocarcinoma (ICC) called The ALIGN Trial. Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S. In Europe, our system is marketed under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT) and has been used at major medical centers to treat a wide range of cancers of the liver. Since January 2019 CHEMOSAT is marketed under an exclusive licensing agreement with medac, a privately held multi-national pharmaceutical company headquartered in Germany and specializing in the treatment and diagnosis of oncological, urological and autoimmune diseases.
Proxy vote wants RS by Dec.18 max 1-75 & allow common up 400M
Only saw alert hour ago but older.
https://seekingalpha.com/filing/4713638?app=1
GUSH ahead Nov 21 AC RS 1-10
Direxion announces 1-for-10 reverse splits of leveraged ETF
Oct. 22, 2019 6:26 AM ET|About: Direxion Daily S&P Oil &... (GUSH)|By: Gaurav Batavia, SA News Editor
Direxion to execute a 1-for-10 reverse split of the outstanding shares of the Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (NYSEARCA:GUSH), effective after the market close on November 21, 2019.
This affectively will decrease the total number of shares outstanding by approximately 90%.
Source: Press Release
PLX Protalix BioTherapeutics proxy for 1-10 to 1-20
Today 4:30PM ET
https://seekingalpha.com/filing/4664626
As part of our efforts to preserve our ongoing clinical development and to realize future benefits of commercial success, our Board of Directors, along with our Management team, have determined that it is in the company’s best interest to make certain changes to our capital structure. Accordingly, we have filed a proxy statement asking our stockholders to approve an amendment to our Certificate of Incorporation proposing the following two changes:
1)
A reverse stock split at a ratio of not less than 1-for-10 and not greater than 1-for-20, with the exact ratio to be set within that range at the discretion of our Board of Directors before the day prior to the special meeting of stockholders without further approval or authorization of our stockholders.
2)
A reduction in the total number of shares of our common stock that we are authorized to issue from 350 million to 120 million shares.
If the proposal to amend our certificate of incorporation is approved, our Board of Directors will set the timing for the reverse stock split and select the specific ratio from within the preceding range of ratios.
BRCOQ Not seeing anything. zero vol day.
Did seem to have had a pop some days, when had vols. No news other than some Inst Holders mentions 4/21 7/21.
21.2M OS is what I see. No sign of any prior RS. Never know. Maybe a small play if goes back down to 0.0002/0.0003 range.
Some kind of carbon, gas reclamation thing. Check Bloomberg for data.
OK based. or was
SCON Superconductor Tech plans R/S 1-2 / 1-10. Proxy 14A
7am ET https://seekingalpha.com/filing/4663630
USOD to RS 1-2 AC Oct. 3 O/S too
Side bit USO itself is slightly lower pre open. 12.13 - 12.14
WALNUT CREEK, Calif., Sept. 23, 2019 /PRNewswire/ -- USCF announced today that it will execute a one-for-two reverse share split that will be effective for shareholders of the United States 3x Short Oil Fund (USOD), a series of the USCF Funds Trust, after the close of the markets on October 3, 2019. Shares of USOD will trade at their post-split prices on October 4, 2019. USOD's ticker symbol, "USOD", will not change, and shares of USOD will continue to trade on the NYSE Arca. USOD's new CUSIP number will be 91733T 505.
Cash for fractional shares.
https://finance.yahoo.com/news/uscf-announces-one-two-reverse-122800362.html?.tsrc=rss
USOD to RS 1-2 AC Oct. 3 O/S too
USO itself is slightly lower pre Open. 12.13 - 12.14
WALNUT CREEK, Calif., Sept. 23, 2019 /PRNewswire/ -- USCF announced today that it will execute a one-for-two reverse share split that will be effective for shareholders of the United States 3x Short Oil Fund (USOD), a series of the USCF Funds Trust, after the close of the markets on October 3, 2019. Shares of USOD will trade at their post-split prices on October 4, 2019. USOD's ticker symbol, "USOD", will not change, and shares of USOD will continue to trade on the NYSE Arca. USOD's new CUSIP number will be 91733T 505.
Cash for fractional shares.
https://finance.yahoo.com/news/uscf-announces-one-two-reverse-122800362.html?.tsrc=rss
WALNUT CREEK, Calif., Sept. 23, 2019 /PRNewswire/ -- USCF announced today that it will execute a one-for-two reverse share split that will be effective for shareholders of the United States 3x Short Oil Fund (USOD), a series of the USCF Funds Trust, after the close of the markets on October 3, 2019. Shares of USOD will trade at their post-split prices on October 4, 2019. USOD's ticker symbol, "USOD", will not change, and shares of USOD will continue to trade on the NYSE Arca. USOD's new CUSIP number will be 91733T 505.
Cash for fractional shares.
https://finance.yahoo.com/news/uscf-announces-one-two-reverse-122800362.html?.tsrc=rss
FVE Five Star R/S 1-10. Close Sep. 30 & O/S. A/S same.
NEWTON, Mass.--(BUSINESS WIRE)-- 8am ET
Reverse stock split to be effective as of close of trading on September 30, 2019
Five Star Senior Living Inc. (FVE) today announced that its board of directors has approved a one-for-ten reverse stock split of its outstanding shares of common stock effective as of the close of trading on September 30, 2019, in order to regain compliance with the minimum $1.00 bid price per share requirement of Nasdaq's Marketplace Rule 5550(a)(2).
At the effective time, each ten (10) Five Star common shares outstanding immediately prior to the effective time will be converted into one (1) issued and outstanding Five Star common share. No fractional common shares will be issued in connection with the reverse stock split. Each Five Star stockholder that would have been entitled to receive a fractional common share as a result of the reverse stock split will receive cash in lieu of such fractional common share. Five Star expects that a new CUSIP number will be issued for the common shares. The Five Star common shares will begin trading on Nasdaq on a split adjusted basis under the existing trading symbol “FVE” at the open of trading on October 1, 2019.
The par value of the Five Star common shares will remain unchanged at $ .01 per share after the reverse stock split. The reverse stock split will reduce the number of common shares issued and outstanding from approximately 50.8 million to approximately 5.1 million. The number of authorized common shares will remain the same.
Equiniti Shareholder Services, or EQ, is acting as the exchange agent for the reverse stock split. EQ will provide instructions to stockholders of record regarding the exchange of stock certificates, as applicable. Stockholders who hold their shares in brokerage accounts or “street name” are not required to take any action to effect the exchange of their shares. Shareholders with questions may contact EQ by calling 855-400-2471.
About Five Star Senior Living Inc.
Five Star Senior Living Inc. is a senior living and healthcare services company that owns, leases and manages senior living communities, including primarily private pay independent and assisted living communities located throughout the U.S. FVE is headquartered in Newton, Massachusetts.
8 Direxion Funds to RS 1-5/1-10 on 6.28.19 JNUG SOXS etc.
https://finance.yahoo.com/news/direxion-announces-reverse-splits-eight-002500667.html?.tsrc=rss
NEW YORK, May 24, 2019 /PRNewswire/ -- Direxion has announced it will execute a reverse split of the issued and outstanding shares of the Direxion Daily Mid Cap Bear 3X Shares, Direxion Daily Small Cap Bear 3X Shares, Direxion Daily Financial Bear 3X Shares, Direxion Daily S&P Oil & Gas Exp. & Prod.Bear 3X Shares, Direxion Daily Natural Gas Related Bull 3X Shares, Direxion Daily Junior Gold Miners Index Bull 3X Shares, Direxion Daily Daily MSCI Real Estate Bear 3X Shares and the Direxion Daily Semiconductor Bear 3X Shares (each a "Fund" and collectively the "Funds"). The total market value of the shares outstanding will not be affected as a result of these splits, except with respect to the redemption of fractional shares, as outlined below.
After the close of the markets on June 27, 2019, the Funds will affect reverse splits of their issued and outstanding shares as follows:
<more>
FCEL FuelCell Energy RS 1-12 at 5pm ET today
Unusual to post 12:45pm ET mid-day.
DANBURY, Conn., May 08, 2019 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today announced that a 1-for-12 reverse stock split will become effective at 5:00 p.m., Eastern time, today and that trading of the Company’s common stock on a post-split basis will begin on May 9, 2019.
Today, the Company filed a Certificate of Amendment of the Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware to effect a reverse stock split of its common stock at a ratio of 1-for-12. Trading of the Company’s common stock on the Nasdaq Global Market will continue under the symbol “FCEL.” The new CUSIP number for the Company’s common stock following the reverse stock split will be 35952H 601.
No fractional shares will be issued as a result of the reverse stock split. A holder of record of common stock on the effective date of the reverse stock split who would otherwise be entitled to a fraction of a share will instead be entitled to receive a cash payment for the fractional interest.
The Company’s transfer agent, American Stock Transfer & Trust Company, will act as exchange agent for the reverse stock split.
Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers’ particular processes, and will not be required to take any action in connection with the reverse stock split.
Registered stockholders holding pre-split shares of the Company’s common stock electronically in book-entry form are not required to take any action to receive post-split shares.
Stockholders of record holding certificates representing pre-split shares of the Company’s common stock as of the effective time will receive a letter of transmittal from American Stock Transfer & Trust Company providing instructions regarding (i) the exchange of shares and (ii) how to receive their cash payment in lieu of fractional shares, if applicable.
The reverse stock split will not change the total number of shares of common stock or preferred stock authorized for issuance by the Company. Additionally, the par value of the Company’s common stock will remain at $0.0001 per share.
The stockholders of the Company approved the reverse stock split at the 2019 Annual Meeting of Stockholders on April 4, 2019, and the Board of Directors of the Company subsequently approved the implementation of the reverse stock split at the ratio of 1-for-12.
Additional information regarding the reverse stock split is available in the definitive proxy statement filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) on February 19, 2019. The definitive proxy statement is available at the Investors page of the Company website at www.fuelcellenergy.com and the SEC website.
About FuelCell Energy
FuelCell Energy, Inc. (FCEL) delivers state-of-the-art fuel cell power plants that provide environmentally responsible solutions for various applications such as utility-scale and on-site power generation, carbon capture, local hydrogen production for both transportation and industry, and long duration energy storage. Our systems cater to the needs of customers across several industries, including utility companies, municipalities, universities, government entities and a variety of industrial and commercial enterprises. With our megawatt-scale SureSource™ installations on three continents and with more than 8.0 million megawatt hours of ultra-clean power produced, FuelCell Energy is a global leader in designing, manufacturing, installing, operating and maintaining environmentally responsible fuel cell distributed power solutions. Visit us online at www.fuelcellenergy.com and follow us on Twitter @FuelCell_Energy.
SureSource, SureSource 1500, SureSource 3000, SureSource 4000, SureSource Recovery, SureSource Capture, SureSource Hydrogen, SureSource Storage, SureSource Service, SureSource Capital, FuelCell Energy, and FuelCell Energy logo are all trademarks of FuelCell Energy, Inc.
Contact:
FuelCell Energy
203.205.2491
ir@fce.com
Source: FuelCell Energy
EARS R/S 1-20 open. had 1-10 on 3/2018
Stock Split in General
Auris Medical Holding Ltd EARS:NASDAQ
Auris Medical Holding Ltd has announced a 1-20 split effective 5/1/19.
VXRT $0.82 P1b oral norovirus vaccine - news close
5 down day candles slide after big gap day. 8.3M OS. News at 4:01pm close caused mild twitch @$0.80s
Doesn't seem to have the usual mega lawsuits facing so many of these
fallen ones. Main issue likely a offering -- size (didn't see).
8am ET April 9
*Vaxart shares are trading lower after the company announced pricing of its public offering of common stock at $1.10 per share.
------------
Vaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
Tue April 16, 2019 4:01 PM|Business Wire|About: VXRT
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vaxart, Inc. (VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced it has started dosing subjects in the randomized cohort of the Phase 1b bivalent norovirus vaccine clinical trial.
“We are delighted to start the randomized portion of the bivalent norovirus phase 1b trial,” said David Taylor, M.D., chief medical officer of Vaxart. “The monovalent GII.4 vaccine tablets performed as expected in the lead-in cohort we just completed, and we look forward to building on the excellent results we observed previously with our monovalent GI.1 vaccine. Norovirus is the leading cause of foodborne illness in the United States and causes significant morbidity and mortality in older adults and the very young. Our oral norovirus vaccine could provide a significant public health benefit for these vulnerable populations in the United States and beyond.”
The Vaxart bivalent norovirus vaccine consists of an oral norovirus GI.1 vaccine tablet and an oral norovirus GII.4 vaccine tablet administered concurrently. The bivalent norovirus Phase 1b trial includes two stages, an open-label lead-in phase which was completed successfully earlier this month, and a randomized, double-blind, placebo-controlled phase which has now started. Both portions of the trial are designed to evaluate safety and immunogenicity. The Company expects to receive topline data from the trial in the second half of 2019.
About Norovirus
Norovirus is recognized as the leading cause of acute gastroenteritis in the United States. It is a common intestinal infection that typically lasts three to five days and is marked by diarrhea, vomiting, abdominal cramps, nausea and sometimes fever. Symptoms can be more severe in older adults and young children and may lead to serious complications including death. Norovirus causes frequent and widespread outbreaks in the military, food industry, travel industry, child care facilities, elderly homes and healthcare facilities.
The U.S. Centers for Disease Control and Prevention (CDC) estimates that norovirus causes approximately 19 to 21 million illnesses in the United States each year, resulting in 56,000 to 71,000 hospitalizations and 570 to 800 deaths, mostly among young children and older adults.
In a recent study by Johns Hopkins University and the CDC, researchers estimated global economic impact of norovirus disease at $60 billion, $34 billion of which occurred in high income countries, including the United States, Europe and Japan.
DARE action AHrs
And been looking for DARE which is jumpy AH without yet seeing news since am other than some ownership filing late today.
Wacky bio one with just 16.8M os, beta 2.3 and had recent spike run to $2+ then drop. But the burst hit my alerts so...
Last Trade $1.13 Change Since Close +0.08 (+7.62%)
BPMX to RS 1-25 4/26 watch DARE
It dropped news just after close. Price banged .09 to .06 - .07 area
04:21 PM EDT, 04/15/2019 (MT Newswires) -- BioPharmX (BPMX) said on Monday its board has approved a reverse 1-for-25 stock split, effective on April 25, and the shares will begin trading on the split-adjusted basis on the NYSE on April 26 as part of its plan to regain compliance with NYSE American listing standards.
Price: 0.0899, Change: 0.00, Percent Change: +1.81
And been looking for DARE which is jumpy AH without yet seeing news since am other than some ownership filing late today.
Wacky bio one with just 16.8M os, beta 2.3 and had recent spike run to $2+ then drop.
Last Trade $1.13 Change Since Close +0.08 (+7.62%)
BioPharmX BPMX RS 1-25 for 4/26
AH drop .09 to .06 - .07 area
04:21 PM EDT, 04/15/2019 (MT Newswires) -- BioPharmX (BPMX) said on Monday its board has approved a reverse 1-for-25 stock split, effective on April 25, and the shares will begin trading on the split-adjusted basis on the NYSE on April 26 as part of its plan to regain compliance with NYSE American listing standards.
Price: 0.0899, Change: 0.00, Percent Change: +1.81
Rite Aid to reverse split shares 1:20 on 4/22
Apr. 10, 2019 4:32 PM ET| Rite Aid Corporation (RAD)|By: Douglas W. House, SA News Editor
The board of Rite Aid (NYSE:RAD) has authorized a 1:20 reverse split of its common stock. Post-split trading will commence on April 22.
nice plays. watching SPIN NCTY CTRC em
PLAG saw it pass CNBC ticker this 9am et, active.
Likely a momo play & has history of several intraday halts for volatility.
RS 10/01/2018 1 for 25
Just showed up AMTD gainers list. RH soon?
AVEO 22.0M +0.33 (57.32%) $0.90
Looking for it to show up in RH lists.
JAZZ wanted AVEO back in Mar 2017 $15-19 range
There's a few others that also seemingly made bids @ same area.
Didn't get chance to know outcomes/why or share sizes compared.
Astra well known for deep pockets and getting what it wants. I'd think they'd just off something enough to know this one off quickly.
Doubt a bid war since why go up against a hungry big boy. But if bid war was ever to happen...
Not sure of share size. Most have 139M now.
Just in for nibble at 0.70 back at 1/31.
Aveo Pharmaceuticals' shares are trading higher after a report the company could be acquired by Astrazeneca for about $800 million to $1.2 billion.
Mar 27, 2019 12:31p ETBenzinga Stock Analysis
R/S to be 1-10 at Open
https://www.streetinsider.com/Press+Releases/Endologix+Announces+Approval+of+Reverse+Stock+Split/15219992.html
IRVINE, Calif.--(BUSINESS WIRE)-- Endologix, Inc. (the “Company”) (NASDAQ: ELGX) previously announced that a proposal was approved at its Special Meeting of Stockholders, held February 22, 2019, authorizing its Board of Directors to amend the Company's certificate of incorporation to effect a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio not less than 1-for-5 and not greater than 1-for-10 (inclusive), with the exact ratio to be set within that range by the Company’s Board of Directors. The number of authorized shares of common stock would remain at 170 million shares, and the number of authorized shares of preferred stock would remain at 5 million shares.?The Company’s Board of Directors had previously directed that the proposal be submitted to the stockholders for approval and has subsequently approved the reverse stock split at a ratio of 1-for-10. The reverse stock split will take effect at 4:00 p.m. ET on March 5, 2019. Beginning with the opening of trading on March 6, 2019, the Company's common stock will trade on the NASDAQ Global Select Market on a reverse stock split-adjusted basis.
Upon the effectiveness of the reverse stock split, every ten shares of the Company's issued and outstanding common stock will be automatically reclassified and converted into one issued and outstanding share of common stock, par value $0.001 per share. As a result of the reverse split, there will be approximately 10.3 million shares of common stock issued and outstanding. The shares of common stock will trade under a new CUSIP number, 29266S304, effective March 6, 2019.?The Company’s trading symbol will remain “ELGX.” All options, warrants, and convertible securities of the Company outstanding immediately prior to the reverse stock split will be adjusted.
No fractional shares of common stock will be issued as a result of the reverse stock split. Stockholders who would otherwise be entitled to receive a fractional share as a result of the reverse stock split will instead receive one whole share of common stock.
The Company has chosen its transfer agent, American Stock Transfer & Trust Company, LLC (“AST”), to act as exchange agent for the reverse stock split.?Stockholders owning shares via a bank, broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, and will not be required to take further action in connection with the reverse stock split, subject to brokers' particular processes.?For those stockholders holding physical stock certificates, AST will send instructions for exchanging those certificates for shares held in book-entry form representing the post-split number of shares. AST can be reached at (800) 937-5449.
About Endologix, Inc.
The Company develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is in endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once an AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 80%, making it a leading cause of death in the U.S. For more information, visit www.endologix.com.
The Nellix® EndoVascular Aneurysm Sealing System and Ovation Alto® Abdominal Stent Graft System, the Company's next generation Ovation system device, are approved only as investigational devices and are not currently approved for commercial purposes in any market.
ELGX Endologix selects R/S 1-10 at Open today
https://www.streetinsider.com/Press+Releases/Endologix+Announces+Approval+of+Reverse+Stock+Split/15219992.html
IRVINE, Calif.--(BUSINESS WIRE)-- Endologix, Inc. (the “Company”) (NASDAQ: ELGX) previously announced that a proposal was approved at its Special Meeting of Stockholders, held February 22, 2019, authorizing its Board of Directors to amend the Company's certificate of incorporation to effect a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio not less than 1-for-5 and not greater than 1-for-10 (inclusive), with the exact ratio to be set within that range by the Company’s Board of Directors. The number of authorized shares of common stock would remain at 170 million shares, and the number of authorized shares of preferred stock would remain at 5 million shares.?The Company’s Board of Directors had previously directed that the proposal be submitted to the stockholders for approval and has subsequently approved the reverse stock split at a ratio of 1-for-10. The reverse stock split will take effect at 4:00 p.m. ET on March 5, 2019. Beginning with the opening of trading on March 6, 2019, the Company's common stock will trade on the NASDAQ Global Select Market on a reverse stock split-adjusted basis.
Upon the effectiveness of the reverse stock split, every ten shares of the Company's issued and outstanding common stock will be automatically reclassified and converted into one issued and outstanding share of common stock, par value $0.001 per share. As a result of the reverse split, there will be approximately 10.3 million shares of common stock issued and outstanding. The shares of common stock will trade under a new CUSIP number, 29266S304, effective March 6, 2019.?The Company’s trading symbol will remain “ELGX.” All options, warrants, and convertible securities of the Company outstanding immediately prior to the reverse stock split will be adjusted.
No fractional shares of common stock will be issued as a result of the reverse stock split. Stockholders who would otherwise be entitled to receive a fractional share as a result of the reverse stock split will instead receive one whole share of common stock.
The Company has chosen its transfer agent, American Stock Transfer & Trust Company, LLC (“AST”), to act as exchange agent for the reverse stock split.?Stockholders owning shares via a bank, broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, and will not be required to take further action in connection with the reverse stock split, subject to brokers' particular processes.?For those stockholders holding physical stock certificates, AST will send instructions for exchanging those certificates for shares held in book-entry form representing the post-split number of shares. AST can be reached at (800) 937-5449.
HMNY wants 1-2 / 1-500 RS vote 3/15
MoviePass parent Helios & Matheson seeks another reverse-stock split of up to 1-for-500 shares
Today 12:54 PM ET (MarketWatch)
Share
Print
Helios & Matheson Analytics Inc. (HMNY), the parent of the film loyalty program MoviePass, has set March 15 as the date for a meeting on its latest plan for a reverse-stock split that would help avert a delisting. In a regulatory filing, the company invited shareholders to a meeting at 10.00 a.m. Pacific Time on that date to vote on a reverse split of its stock at a ratio of 1-for-2 shares up to 1-for-500 shares, . The stock has closed below the $1 threshold for an exchange listing since July. It has closed beneath a nickel every day since August and was last quoted at 1 cent. The data company has struggled to make MoviePass profitable and has been burning through cash. It first bought a majority stake in the program in 2017 and immediately cut the price to $9.95 a month allowing subscribers see a film of their choice every day. When that proved untenable, it changed the terms of its offering, limiting access to bigger films and restricting customers to certain showings. It has already implemented a 1-for-250 reverse stock split and has sold preferred stock and convertible notes to raise fresh funds. New York Attorney General Barbara Underwood has launched a securities fraud investigation into the company.
-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
TTNP - TDA alert Sat. - Buy Rec & eps +
TDA site showing OS of 13M Mkt cap $18.8M and a bit rise pre-Fri.
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose 5.6 percent to $0.24 in pre-market trading. Titan Pharma reported a 1-for-6 stock split effective January 24, 2019.
--------
Watch List Alert
Sent: Sat Jan 26 2019 9:00:07 AM EST
Change in Consensus Earnings Estimate
EPS estimate up $0.25 to $-0.05 for quarter ending 12/2018
TTNP Titan Pharmaceuticals Inc
Quote Details Estimate Details Consensus Info
Last Price $1.45
Last Update 9:00am ET
Change 6.5744 (81.93%)
Open $1.38
Prev Close $8.02
Day Range $1.18 - $1.47
P/E Ratio --
Volume 2,401,882
Quarter Ending 12/2018
# Estimates 1
Current Est $-0.05
Prev $-0.30
Range $-0.05
- $-0.05
Current Rec Buy
Prev Hold
Range Buy - Buy
Last Update: 9:00am ET
Past performance of a security, industry or sector does not guarantee future results or success.
The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2019 is proprietary to Dow Jones & Company, Inc.
Please do not reply to this e-mail from Markit On Demand. Markit On Demand and TD Ameritrade are separate unaffiliated companies and are not responsible for each other's service. For questions regarding your brokerage account, please contact TD Ameritrade Client Services at 1-800-669-3900.
To stop receiving this alert from TD Ameritrade, please click here to update your subscription settings. You may also unsubscribe from all of your alerts using the link above. As always, you can manage all of your alert settings by logging into your TD Ameritrade account and navigating to Research & Ideas > Alerts.
Watching for any serious UN news over Venz
If nothing much swings GUSH then prob going higher just on its own momo.
Bulls seem to have the weight so far.
Venz is bit of a keystone wild card longer term as both sides lining up. If US wins then the flow resumes and some of ex-pat oil guys test returning.
If US looks failing to get the juice going again big timey well US shale even more key than now.
Odd how Venz people fled as oil money dried up while Saudi pop just hangs around on the gov't/kingdom teat puts out. Which one you expect will break, not a hard call.
I'm guessing take just 1-2 yrs to get the Venz light flowing biggly.
Rite Aid to reverse split shares 1-10-15-20 3.21.19
Jan. 25, 2019 4:30 PM ET|About: Rite Aid Corporation (RAD)|By: Douglas W. House, SA News Editor
Aimed at regaining compliance with NYSE's listing standard of a $1 minimum bid price, Rite Aid (NYSE:RAD) will reverse split its common stock either 1:10, 1:15 or 1:20 subsequent to a vote from shareholders on March 21.
A preliminary proxy statement will be filed later today.
+++++++++++ Proxy details below Given size of the 1B+ OS likely 1-20
https://ih.advfn.com/stock-market/NYSE/rite-aid-RAD/stock-news/79123695/proxy-statement-notice-of-shareholders-meeting-p
Chart inverted H&S formed
Certainly looks like USO clenching cheeks here on right shoulder, and encountering the downtrend line. Once dust settles $11.50 - 12 should indicate the up move is underway. Or whole thing just flat lines or fails.
Easy bracket play. GUSH also one I've played but man what a day shaker.
GUSH & DRIP RS histories. GUSH overdue
GUSH Split History Table
Date Ratio
07/16/1998 1 for 2
03/24/2016 1 for 10
04/28/2017 1 for 1
05/01/2017 2 for 1
DRIP Split History Table
Date Ratio
03/24/2016 4 for 1
08/25/2016 1 for 5
Jetlines Announces Up to $15M Financing Commitment from Leading European Airline
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR RELEASE TO U.S. NEWSWIRE SERVICES
VANCOUVER, British Columbia , Nov. 27, 2018 (GLOBE NEWSWIRE) -- Canada Jetlines Ltd. (JET: TSX-V) (the “Company” or “Jetlines”) is pleased to announce that it has entered into a subscription agreement (the “Subscription Agreement”) with SmartLynx Airlines SIA (“SmartLynx”) for financing commitments of up to $15 million (the “Offering”). SmartLynx specializes in full-service ACMI (Aircraft-Crew-Maintenance-Insurance) aircraft lease services and is the leading ACMI provider in Europe for Airbus A320 aircraft. SmartLynx aircraft has been utilized by major airlines including Norwegian, EasyJet , Thomas Cook and TUI.
“This financing transaction with SmartLynx provides further validation of the Jetlines business plan and the need for a true ultra-low cost carrier in Canada . This also provides endorsement from a seasoned European airline that flies aircraft for some of the most successful ultra-low cost carrier airlines in the world. We look forward to working with the SmartLynx group as we continue to build out the business plan in preparation for launch,” commented Mark Morabito , Executive Chairman of Jetlines.
Javier Suarez , CEO of Jetlines added “In addition to the great value added by the investment SmartLynx is making in Jetlines, having them as our partner brings in a good number of synergies that will translate into significant long-term operational savings. SmartLynx reputation and broad network will help Jetlines accomplish our near-term goals”.
Zygimantas Surintas, CEO of SmartLynx commented “Expansion of our operations into new markets is a strategic long-term priority for SmartLynx, and the Canadian market is among those we have been looking at for several years. We are excited about the opportunity for partnership with Jetlines – not only through SmartLynx’s investment but also through SmartLynx’s ability to contribute our years of experience in airline operations, aircraft leases, maintenance operations and other matters to help Jetlines succeed. The SmartLynx team believes in the ULCC model in Canada and hopes that it can play a part in bringing cheaper air travel to Canadians.”
Details of the Offering
The Offering will consist of 22,727,272 subscription receipts of the Company (“Subscription Receipts”) at a price of $0.33 per Subscription Receipt (the “Offering Price”), for gross proceeds of $7.5 million . The Subscription Receipts will be issued pursuant to the terms of a Subscription Receipt Agreement (the “Subscription Receipt Agreement”) between the Company, SmartLynx and an escrow agent. SmartLynx also has the option exercisable for a period of twelve months following the closing of the Offering to complete a second financing for variable voting shares for additional gross proceeds of up to $7.5 million at the discounted market price at the time it exercises its option (the “Option”).
Each Subscription Receipt will entitle SmartLynx to receive, without payment of additional consideration or further action on the part of the holder, one unit of the Company (each a “Unit” and collectively the “Units”), upon receipt by the escrow agent, prior to August 31, 2019 (the “Deadline”) of a release notice from the Company and SmartLynx (the “Release Notice”), confirming that: (a) the Company has raised additional gross proceeds of $40 million (the “Funding Milestone”) from a subsequent financing by May 31, 2019 (such completion date subject to waiver by SmartLynx); (b) the receipt by the Company’s subsidiary, Canada Jetlines Operations Ltd. (“Jetlines Operations”), of its air operator certificate from Transport Canada; and (c) no termination event has occurred.
Each Unit will consist of one variable voting share of the Company and one common share purchase warrant (each, a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one variable voting share of the Company at a price of $0.45 at any time up to 5:00 p.m. (Vancouver time) on the date which is 36 months from the closing date.
If: (i) the Release Notice is not delivered by the Deadline, or (ii) the Offering is terminated in accordance with the terms of the Subscription Receipt Agreement, then SmartLynx will be entitled to receive an amount per Subscription Receipt equal to the Offering Price and an entitlement to the interest earned thereon. Any shortfall will be funded by the Company. In addition, the Company is obligated to pay a termination fee of US$250,000 if the Company has not achieved the Funding Milestone by May 31, 2019 or commits certain other material breaches and SmartLynx terminates the Subscription Agreement.
The net proceeds of the Offering will be used to further the business objectives of Jetlines in launching an ultra-low cost airline carrier in Canada, including advancing the licensing process, augmenting the leadership team with operations and commercial personnel, branding and marketing activities, as well as advance internet, digital media and IT systems initiatives.
It is expected that SmartLynx will become an insider of the Company on conversion of the Subscription Receipts.
Details of the Commercial Arrangement
In connection with the Offering, Jetlines Operations and SmartLynx will enter into an agreement whereby SmartLynx shall provide ACMI (Aircraft-Crew-Maintenance-Insurance) services to Jetlines Operations during the following eight winter seasons. This agreement will allow Jetlines to increase its capacity in the market during the very busy Canadian Winter Season. In addition, SmartLynx and the Company will enter into a two-year agreement that will provide Jetlines with services and certain proprietary software meant to support Jetlines during the early stage of their operations.
The Company, Jetlines Operations and SmartLynx will also enter into a framework agreement (the “Framework Agreement”) in connection with the closing of the Offering that will govern aspects of the relationship between the parties. The Framework Agreement will cover matters including the right of SmartLynx to appoint a single Board member to the Company and Jetlines Operations, rights to participate on Board committees, arrangements regarding the review of aircraft leases, the grant of a pro-rata right to SmartLynx to participate in future financings and certain other rights detailing with operational and expenditure matters of the Company and Jetlines Operations.
The closing of the Offering is conditional on the satisfaction of conditions to closing contained in the Subscription Agreement, which conditions include, among other things, approval of the TSX Venture Exchange for the Offering and the execution of the Subscription Receipt Agreement and the execution of the agreements referred to above. It is expected that the Offering will close on or before December 24, 2018.
About SmartLynx Airlines SIA
SmartLynx Airlines was founded in 1992 as a private airline. Today it is the leading ACMI (Aircraft-Crew-Maintenance-Insurance) provider in the EU on Airbus aircrafts. As an EU airline, SmartLynx Airlines complies with IOSA and EASA international quality standards, and has access to free route airspace. In 2019, SmartLynx’s fleet will consist of 20 Airbus aircrafts, flying routes in Europe and Asia. SmartLynx flight crew members represent more than 17 nationalities, speak multiple languages. The average experience of SmartLynx’s captains exceeds 5300 block hours and first officers exceeds 1900 block hours.
For more information on SmartLynx, please visit their website at www.smartlynx.aero
About Canada Jetlines Ltd.
Canada Jetlines is set to become Canada’s first true Ultra-Low Cost Carrier (ULCC) airline, with plans to operate flights across Canada and provide non-stop service from Canada to the United States, Mexico and the Caribbean. The Company plans to commence operations with the Airbus A320 fleet, the most widely used aircraft for ultra-low cost carriers worldwide. Jetlines is led by a board and management team with extensive experience and expertise in low-cost airlines, start-ups and capital markets. The Company was granted an unprecedented exemption from the Government of Canada that will permit it to conduct domestic air services while having up to 49% foreign voting interests.
For more information on Jetlines, please visit our website at www.jetlines.ca.
ON BEHALF OF THE BOARD
"Mark J. Morabito" Executive Chairman
Canada Jetlines is part of the King & Bay group of companies. King & Bay is a merchant bank that specializes in identifying, funding, developing and supporting growth opportunities in the resource, aviation, and technology sectors.
For more information, please contact: Toll Free: 1-833-226-5387 Email: investor.relations@jetlines.ca
Cautionary Note Regarding Forward-Looking Information
This news release contains "forward-looking information" concerning anticipated developments and events that may occur in the future. Forward-looking information contained in this news release includes, but is not limited to, statements with respect to (i) the commencement of operations and the success of expected future operations of the Company; (ii) the completion of the Offering; (iii) the satisfaction of the conditions to closing of the Offering, (iv) the satisfaction of the escrow release conditions; or (iv) the use of proceeds from the Offering.
In certain cases, forward-looking information can be identified by the use of words such as "plans", "expects" "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or " or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Forward-looking information contained in this news release is based on certain factors and assumptions regarding, among other things, the satisfaction of the conditions to closing of the Offering, the satisfaction of the escrow release conditions, the terms contained in the executed agreements to be entered into by the Company or its subsidiaries with SmartLynx, the receipt of financing to commence airline operations, the accuracy, reliability and success of the Jetlines’ business model; the timely receipt of governmental approvals; the timely commencement of operations by Jetlines and the success of such operations; the legislative and regulatory environments of the jurisdictions where the Jetlines will carry on business or have operations; the impact of competition and the competitive response to the Jetlines’ business strategy; and the availability of aircraft. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect.
Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include risks related to, the ability to obtain financing at acceptable terms, the impact of general economic conditions, domestic and international airline industry conditions, future relations with SmartLynx, volatility of fuel prices, increases in operating costs, terrorism, pandemics, natural disasters, currency fluctuations, interest rates, risks specific to the airline industry, the ability of management to implement Jetlines’ operational strategy, the ability to attract qualified management and staff, labour disputes, regulatory risks, including risks relating to the acquisition of the necessary licenses and permits; risks related to disputes under the agreement with Boeing to acquire 737-Max aircraft, and the additional risks identified in the "Risk Factors" section of the Company's reports and filings with applicable Canadian securities regulators. There is no assurance that the closing of the Offering will occur or if it does occur that the escrow release conditions will be satisfied or that SmartLynx will exercise the Option.
Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information is made as of the date of this news release. Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding U.S. Securities Act
No securities regulatory authority has expressed an opinion about the securities described herein. No Company securities have been or will be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state, district or commonwealth of the United States (as defined in Regulation S under the U.S. Securities Act). Accordingly, these securities may not be offered or sold, directly or indirectly, within the United States or to or for the account or benefit of any "U.S. Person" (as defined in Regulation S under the U.S. Securities Act), absent an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release in the United States or any jurisdiction where such offer or sale would be unlawful, or for the account or benefit of any U.S. Person or person within the United States.
Don't know importance of this - home grow kits
Not sure if any home growers would need/want a lab test but who knows.
Maybe if a large group was doing a roof garden or something they'd like a test.
AUSTIN, Texas , Aug. 22, 2018 /PRNewswire/ -- The Access to Cannabis for Medical Purposes Regulations (ACMPR) was announced by the Canadian Government on Aug. 11, 2016. It legalized the home-growing, production and cultivation of cannabis in Canada for medical purposes. On Oct. 17 , recreational use will also be legalized.
At least 31 states and Washington D.C. also have some form of marijuana legalization. The recreational use of cannabis is legal in 9 states: Alaska , California , Colorado , Maine , Massachusetts , Nevada, Oregon, Vermont, and Washington plus the District of Columbia , and decriminalized in another 13 states plus the U.S. Virgin Islands .
According to Newsweek:
"Several other states, besides Michigan , have ballot measures coming up later this year. Legalization also enjoys bipartisan support among voters, as 62 percent of Republicans younger than 40 support ending prohibitions on marijuana consumption, according to a Pew Research poll released in January. Among Democrats, the percentage is 69 percent, and among independents, it is 65 percent. Overall, 61 percent of Americans are estimated to support legalizing pot."
People are starting to embrace the idea that pot is going to become legal and is legal in many states. People are realizing that they can grow it at home now and save a significant amount that they would pay to dispensaries. The cost can be quite high for lab-grown medicinal marijuana. There are a couple of solutions on the market that embrace the idea of growing indoor at home, but are also cost prohibitive. While some of the other systems have a starting price of $1500 , Klever Garden's prices start at $349 for a full soil solution and $500 for a hydroponic solution.
Klever Garden , an Austin Texas based company Kickstarted "Klever Box" that is designed to automatically grow plants, vegetables, and Cannabis with very little work. They designed a system that allows growers to obtain the freshest, highest quality harvests possible by letting growers set the conditions on a mobile app. The system does the rest.
The Klever Garden Box was founded by Titon Hoque , a former IBM employee living in Austin, Texas who has a passion for growing and a passion for technology. He along with Chad Caron , Animesh Banjerjee, and Enam Hoque created a system that anyone could use to grow fruits and vegetables. In the early phases as they market tested their idea, they began to realize that Marijuana growers had a need for such a device. So they included Cannabis growing to their garden profiles and will support Cannabis growers in their community.
"We started this project a couple of years ago while I struggled with my own fruit and vegetable gardens outdoors. I was tired of killing my plants every time I was out of town or forgot to water my plants," says Titon. "And hydroponically, with my busy schedule, I just couldn't create the right conditions for my plants. I spent hours a day, trying to keep the system in equilibrium."
Having grow profiles in their system based on the exact grow conditions that specific strains of cannabis prefer has led to immense yields, Klever Garden claims. This has led them to integrate a community feature in their app which allows growers to use profiles from other users who have had success with a particular strain. The app also allows users to save and share their profiles when they want repeatable results.
The biggest differentiator for Klever Garden is being able to wirelessly control multiple gardens simultaneously running different grow profiles. They achieve this by creating add-on Wi-Fi outlets to their unit. With the same Klever Box, buying a few $50 add-ons allows for a whole new garden that is managed by the system. For marijuana growers, that means clones can be raised in one grow tent while mother-plants can be grown in another grow tent.
Klever Garden has been a long supporter of controlled environment gardens, specifically grow tents due to several benefits they offer: low cost, high efficiency, unlimited sizes, form factors, durability, lightness, and portability.
Using the system and the mobile application appears to be very straightforward. They provide a video on how to set up the system in 30 minutes or less. The system comes with all of the sensors, hoses for water, and sprinklers for misting. Users can plug in their own lights, fans, humidifiers, dehumidifiers, CO2 generators, and a host of other devices. Another option is to purchase their entire Klever Full Solution that comes with everything needed to grow hydroponically. Only seeds, a choice of minerals, and PH are required.
Users tell the app which device is connected to which port on the Klever Box. Then choose a profile for the specific strain to be grown and that's really it. It will keep the PH and minerals at the right levels. It will provide the right amount of light and ventilation to provide a crop of consistently high quality.
About Klever Garden
Based in Austin, Texas , Klever Garden creates automated internet-connected devices and solutions for growing fruits, vegetables, and herbs. They have currently launched a Kickstarter for a Klever Soil Box and Hydroponic Box that is geared for small growers to commercial ones. They also are developing several other solutions including vertical growing and desktop growing.
For more information, visit: http://www.klevergarden.com
Visit their crowdfunding campaign on:
Kickstarter: https://www.kickstarter.com/projects/436070270/klever-garden-smart-autonomous-growing-made-easy
Indiegogo: https://www.indiegogo.com/projects/klever-garden-smart-autonomous-growing-made-easy-food-arduino/x/19164358
Related Images
a-robot-can-grow-marijuana-for-you.jpg A robot can grow Marijuana for you from seed to harvest! Klever Garden , an Austin Texas based company Kickstarted a new Klever Box that is designed to automatically grow plants, vegetables, and Cannabis automatically for you with very little required from you. They designed a system that allows growers to grow the freshest, highest quality, and best quality marijuana possible by letting growers set the conditions on a mobile app. The system does the rest
the-klever-box.png The Klever Box Designed to plug in a number of devices such as fans, lights, humidifiers. And connect a number of included sensors for PH, minerals, temperature, humidity. etc.
Related Video
Considering kind of day ARYC holds up
In a several day period of lowish volume for it so pretty due for an equal few days of raised volumes. So shows the pattern.
Suspect one further good piece of news along lines of "major chain" finger stick analysis should see more in run.
Always do like the stair step kind of build.
At higher end, played BIOC other day & looking to exit today no matter what.
Thanks MG nice thoughts. & The Glades
There was a short years cable/tv show The Glades I think as a detective series. I loved my trip through there back 1979. Felt like another world.
Lakes and canals. That was just before Vice & South Beach.
Funny just read Miami plans/voted? this "World's Largest Mall" thingie.
Whole mess of combo pieces like theaters, plays, shopping, whatever the hell they can pour into it. Hope they build it far from the shore or the local flooding will be brutal. Imagine tons of sand & concrete will press the whole state lower by 2" lol. Thought it was enough to just have the fine & decorative arts revival there. Miami never seems to be lacking in drive and sheer moxie!
As to pennies & your alert system plans. For sure the HMNY kind are just pin money. Something to tease self with away from the main plays like Big Energy today. Market seems to like strength in that realm as a signal overall market is better than past DOW days would indicate.
Early jumps in ABIL after big yest but red candle now. Ditto red candle for SLNO. CRC 42 ish at new higher high breakout from 41 resist for while.
KMX rocket gapper. HOS cheaper gap 3.69 but hard R at 4.
Be well, enjoy weather.
DIGX yes see Vol again 11M+ now @5
Nice to see holding its own in a sloppy overall mkt.
Guess won't post my other plays that aren't trips.
Trips on watch SANP PZOO MLCG FBEC MLCG they are stalled tho
NVIV hmm true POS but maybe
Hit way hard on PO this am. $ losing durgger but aren't all the little ones. Nasdaq w/ 2 RS. Just a bottom fish from looong slide down and wash out here. Or goes to the $1. 1.85 -1.52
DIGX played this in past several times.
Don't know if the biz theme is lot dif now, just sitting on a lower entry. Was looking at it few times past months.
Thing is each time I bought in <0.0005 the thing soon ran to .001 or .0015 areas. This time it's been a tease. Was just sitting there until the lately volumes that were a trigger before.
I suspect if see a 6, 7 move one day by 11am ET there's .001/.0015 in cards. Otherwise a long sleepy summer.
Course I'm biased since the prior moves came quicker. Lot of the old faves haven't done much so this is worth a watch. It moved fast back then so we'll know soon.